September 07, (THEWILL) — The Impact Investors Foundation (IIF) is now accepting nominations for its Annual Awards for Impact Investing. This event has become one of the most prominent recognitions for enterprises and individuals driving social and environmental...
The Democratic Republic of the Congo (DRC) has commenced a pivotal Phase 2/3 clinical trial to determine whether vaccine candidates can protect against the deadly Bundibugyo virus, following the vaccination of the first participant in Bunia.